Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000.

Jain MK, Skiest DJ, Cloud JW, Jain CL, Burns D, Berggren RE 2003 Apr Clin. Infect. Dis. 8 36 1030-8

A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America.

Sterling RK, King WC, Khalili M, Chung RT, Sulkowski M, Jain MK, Lisker-Melman M, Ghany MG, Wong DK, Hinerman AS, Bhan AK, Wahed AS, Kleiner DE, 2021 Mar Hepatology

Low Rates of Hepatitis B Virus Treatment Among Treatment-Eligible Patients in Safety-Net Health Systems.

Wong RJ, Jain MK, Therapondos G, Niu B, Kshirsagar O, Thamer M, 2021 Mar J Clin Gastroenterol

Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems.

Wong RJ, Jain MK, Therapondos G, Niu B, Kshirsagar O, Thamer M, 2021 Mar Am J Gastroenterol

Self-efficacy as a mediator of patient navigation interventions to engage persons living with HIV and substance use.

Traynor SM, Metsch LR, Gooden L, Stitzer M, Matheson T, Tross S, Carrico AW, Jain MK, Del Rio C, Feaster DJ, 2021 Feb Drug Alcohol Depend 221 108567

The risk of depression among racially diverse people living with HIV: the impact of HIV viral suppression.

Jain MK, Li X, Adams-Huet B, Tiruneh YM, Luque AE, Duarte P, Trombello JM, Nijhawan AE, 2020 Sep AIDS Care 1-9

Fatty Liver Disease in a Prospective North American Cohort of Adults with HIV and Hepatitis B Coinfection.

Khalili M, King WC, Kleiner DE, Jain MK, Chung RT, Sulkowski M, Lisker-Melman M, Wong DK, Ghany M, Sanyal A, Sterling RK, 2020 Sep Clin. Infect. Dis.

Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America.

Thompson MA, Horberg MA, Agwu AL, Colasanti JA, Jain MK, Short WR, Singh T, Aberg JA, 2020 Nov Clin Infect Dis

Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C Treatment.

Wong RJ, Jain MK, Therapondos G, Shiffman ML, Kshirsagar O, Clark C, Thamer M, 2020 Mar-Apr J Clin Exp Hepatol 2 10 114-123

Initiation of Antiretroviral Therapy in the Hospital is Associated with Linkage to HIV Care for Persons Living with HIV and Substance Use.

Jacobs P, Feaster DJ, Pan Y, Gooden L, Daar ES, Lucas G, Jain MK, Marsh E, Armstrong WS, Rodriguez A, Del Rio C, Metsch LR, 2020 Jun Clin. Infect. Dis.

Infectious Diseases Society of America Guidelines on Infection Prevention for Health Care Personnel Caring for Patients with Suspected or Known COVID-19.

Lynch JB, Davitkov P, Anderson DJ, Bhimraj A, Cheng VC, Guzman-Cottrill J, Dhindsa J, Duggal A, Jain MK, Lee GM, Liang SY, McGeer A, Lavergne V, Murad MH, Mustafa RA, Morgan RL, Falck-Ytter Y, Sultan S, 2020 Jul Clin. Infect. Dis.

Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial.

Neilan TG, Nguyen KL, Zaha VG, Chew KW, Morrison L, Ntusi NAB, Toribio M, Awadalla M, Drobni ZD, Nelson MD, Burdo TH, Van Schalkwyk M, Sax PE, Skiest DJ, Tashima K, Landovitz RJ, Daar E, Wurcel AG, Robbins GK, Bolan RK, Fitch KV, Currier JS, Bloomfield GS, Desvigne-Nickens P, Douglas PS, Hoffmann U, Grinspoon SK, Ribaudo H, Dawson R, Goetz MB, Jain MK, Warner A, Szczepaniak LS, Zanni MV, 2020 Jul J. Infect. Dis. Supplement_1 222 S63-S69

Role of Inflammatory Biomarkers in the Prevalence and Incidence of Hypertension Among HIV-Positive Participants in the START Trial.

Ghazi L, Baker JV, Sharma S, Jain MK, Palfreeman A, Necsoi C, Murray DD, Neaton JD, Drawz PE, 2020 Jan Am. J. Hypertens. 1 33 43-52

Predictors for Poor Linkage to Care Among Hospitalized Persons Living with HIV and Co-Occurring Substance Use Disorder.

Summers N, Colasanti J, Feaster D, Armstrong W, Rodriguez A, Jain M, Jacobs P, Metsch L, Del Rio C, 2020 Jan AIDS Res. Hum. Retroviruses

Patient and Provider-Level Barriers to Hepatitis C Screening and Linkage to Care: A Mixed-Methods Evaluation.

Higashi RT, Jain MK, Quirk L, Rich NE, Waljee AK, Turner BJ, Lee SC, Singal AG, 2020 Feb J. Viral Hepat.

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.

Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, Sandkovsky U, Brown SM, Knowlton KU, Self WH, Files DC, Jain MK, Benfield T, Bowdish ME, Leshnower BG, Baker JV, Jensen JU, Gardner EM, Ginde AA, Harris ES, Johansen IS, Markowitz N, Matthay MA, Østergaard L, Chang CC, Davey VJ, Goodman A, Higgs ES, Murray DD, Murray TA, Paredes R, Parmar MKB, Phillips AN, Reilly C, Sharma S, Dewar RL, Teitelbaum M, Wentworth D, Cao H, Klekotka P, Babiker AG, Gelijns AC, Kan VL, Polizzotto MN, Thompson BT, Lane HC, Neaton JD, 2020 Dec N Engl J Med

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.

Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, Marconi VC, Ruiz-Palacios GM, Hsieh L, Kline S, Tapson V, Iovine NM, Jain MK, Sweeney DA, El Sahly HM, Branche AR, Regalado Pineda J, Lye DC, Sandkovsky U, Luetkemeyer AF, Cohen SH, Finberg RW, Jackson PEH, Taiwo B, Paules CI, Arguinchona H, Goepfert P, Ahuja N, Frank M, Oh MD, Kim ES, Tan SY, Mularski RA, Nielsen H, Ponce PO, Taylor BS, Larson L, Rouphael NG, Saklawi Y, Cantos VD, Ko ER, Engemann JJ, Amin AN, Watanabe M, Billings J, Elie MC, Davey RT, Burgess TH, Ferreira J, Green M, Makowski M, Cardoso A, de Bono S, Bonnett T, Proschan M, Deye GA, Dempsey W, Nayak SU, Dodd LE, Beigel JH, 2020 Dec N Engl J Med

Access by English and Non-English Speakers Is Needed to COVID-19A Clinical Trials.

Jain MK, Rollins N, Jain R, 2020 Apr Clin. Infect. Dis.

HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens.

Huhn GD, Ramgopal M, Jain MK, Hinestrosa F, Asmuth DM, Slim J, Goldstein D, Applin S, Ryu JH, Jiang S, Cox S, Das M, Nguyen-Cleary T, Piontkowsky D, Guyer B, Rossaro L, Haubrich RH, 2020 PLoS ONE 1 15 e0224875

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial.

Davey RT, Fernández-Cruz E, Markowitz N, Pett S, Babiker AG, Wentworth D, Khurana S, Engen N, Gordin F, Jain MK, Kan V, Polizzotto MN, Riska P, Ruxrungtham K, Temesgen Z, Lundgren J, Beigel JH, Lane HC, Neaton JD, 2019 Nov Lancet Respir Med 11 7 951-963

Clinical and Sociobehavioral Prediction Model of 30-Day Hospital Readmissions Among People With HIV and Substance Use Disorder: Beyond Electronic Health Record Data.

Nijhawan AE, Metsch LR, Zhang S, Feaster DJ, Gooden L, Jain MK, Walker R, Huffaker S, Mugavero MJ, Jacobs P, Armstrong WS, Daar ES, Sullivan M, Del Rio C, Halm EA 2019 Mar J. Acquir. Immune Defic. Syndr. 3 80 330-341

Evaluating non-invasive markers to identify advanced fibrosis by liver biopsy in HBV/HIV coinfected adults.

Sterling RK, King WC, Wahed AS, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG, 2019 Jun Hepatology

Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study.

Pinato DJ, Allara E, Chen TY, Trevisani F, Minguez B, Zoli M, Harris M, Dalla Pria A, Merchante N, Platt H, Jain M, Caturelli E, Kikuchi L, Pineda J, Nelson M, Farinati F, Rapaccini GL, Aytaman A, Yin M, Tan CK, Bower M, Giannini EG, Bräu N 2019 Feb J. Clin. Oncol. 4 37 296-304

Evaluation of a multifaceted intervention to reduce health disparities in hepatitis C screening: a pre-post analysis.

Jain MK, Rich NE, Ahn C, Turner BJ, Sanders JM, Adamson B, Quirk L, Perryman P, Santini NO, Singal AG, 2019 Apr Hepatology

Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study.

Sterling RK, Wahed AS, King WC, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG 2018 Nov Am. J. Gastroenterol.

Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment.

Wong RJ, Jain MK, Therapondos G, Shiffman ML, Kshirsagar O, Clark C, Thamer M 2018 Mar Am. J. Gastroenterol.

Has Access to HCV Therapy Changed for Patients with Mental Health or Substance Use Disorders in the DAA Period?

Jain MK, Thamer M, Therapondos G, Shiffman ML, Kshirsagar O, Clark C, Wong RJ 2018 Jul Hepatology

Significant Increase in Risk of Fibrosis or Cirrhosis at Time of HCV Diagnosis for Hispanics With Diabetes and Obesity Compared With Other Ethnic Groups.

Turner BJ, Wang CP, Melhado TV, Bobadilla R, Jain MK, Singal AG 2018 Dec Clin. Gastroenterol. Hepatol.

Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection.

Whitmill A, Kim S, Rojas V, Gulraiz F, Afreen K, Jain M, Singh M, Park IW 2018 PLoS ONE 8 13 e0202524

The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinoma.

Pinato DJ, Sharma R, Citti C, Platt H, Ventura-Cots M, Allara E, Chen TY, Dalla Pria A, Jain M, Mínguez B, Kikuchi L, Kaufman West E, Merli M, Kaplan DE, Hasson H, Marks K, Nelson M, Núñez M, Aytaman A, Bower M, Bräu N 2017 Oct Aliment. Pharmacol. Ther.

Prospective longitudinal substance use patterns in patients preparing for hepatitis C treatment.

North CS, Pollio DE, Sims OT, Jain MK, Hong BA 2017 Oct J Dual Diagn 0

Effectiveness of direct-acting antiviral therapy for hepatitis C in difficult-to-treat patients in a safety-net health system: a retrospective cohort study.

Yek C, de la Flor C, Marshall J, Zoellner C, Thompson G, Quirk L, Mayorga C, Turner BJ, Singal AG, Jain MK 2017 Nov BMC Med 1 15 204

Missed Initial Medical Visits: Predictors, Timing, and Implications for Retention in HIV Care.

Nijhawan AE, Liang Y, Vysyaraju K, Muñoz J, Ketchum N, Saber J, Buchberg M, Venegas Y, Bullock D, Jain MK, Villarreal R, Taylor BS 2017 May AIDS Patient Care STDS 5 31 213-221

Analysis of an ordinal endpoint for use in evaluating treatments for severe influenza requiring hospitalization.

Peterson RL, Vock DM, Powers JH, Emery S, Cruz EF, Hunsberger S, Jain MK, Pett S, Neaton JD 2017 Mar Clin Trials 1740774517697919

An effectiveness study of group psychoeducation for hepatitis C patients in community clinics.

North CS, Pollio DE, Sims OT, Jain MK, Brown GR, Downs DL, Lisker-Melman M, Hong BA 2017 Feb Eur J Gastroenterol Hepatol

Immediate antiretroviral therapy reduces risk of infection-related cancer during early HIV infection.

Borges ÁH, Neuhaus J, Babiker AG, Henry K, Jain MK, Palfreeman A, Mugyenyi P, Domingo P, Hoffmann C, Read TR, Pujari S, Meulbroek M, Johnson M, Wilkin T, Mitsuyasu R 2016 Sep Clin. Infect. Dis.

Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.

Metsch LR, Feaster DJ, Gooden L, Matheson T, Stitzer M, Das M, Jain MK, Rodriguez AE, Armstrong WS, Lucas GM, Nijhawan AE, Drainoni ML, Herrera P, Vergara-Rodriguez P, Jacobson JM, Mugavero MJ, Sullivan M, Daar ES, McMahon DK, Ferris DC, Lindblad R, VanVeldhuisen P, Oden N, Castellón PC, Tross S, Haynes LF, Douaihy A, Sorensen JL, Metzger DS, Mandler RN, Colfax GN, del Rio C 2016 Jul JAMA 2 316 156-70

An assessment of concurrent drug and alcohol use among patients seeking treatment for hepatitis C.

Sims OT, Pollio DE, Hong BA, Jain MK, Brown GR, North CS 2016 Feb Ann Clin Psychiatry 1 28 31-6

Faldaprevir and pegylated interferon a-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV.

Dieterich D, Nelson M, Soriano V, Arastéh K, Guardiola JM, Rockstroh JK, Bhagani S, Laguno M, Tural C, Ingiliz P, Jain MK, Stern JO, Manero M, Vinisko R, Kort J 2015 Mar AIDS 5 29 571-81

Health Beliefs and Co-morbidities Associated with Appointment-Keeping Behavior Among HCV and HIV/HCV Patients.

Pundhir P, North CS, Fatunde O, Jain MK 2015 Jul J Community Health

Half of 30-Day Hospital Readmissions Among HIV-Infected Patients Are Potentially Preventable.

Nijhawan AE, Kitchell E, Etherton SS, Duarte P, Halm EA, Jain MK 2015 Jul AIDS Patient Care STDS

Assessment of arterial elasticity among HIV-positive participants with high CD4 cell counts: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Baker J, Engen N, Huppler Hullsiek K, Stephan C, Jain M, Munderi P, Pett S, Duprez D 2015 Apr HIV Med. 16 Suppl 1 109-18

Micro-RNA-122 levels in acute liver failure and chronic hepatitis C.

Dubin PH, Yuan H, Devine RK, Hynan LS, Jain MK, Lee WM 2014 Jun J. Med. Virol.

Acute and chronic immune biomarker changes during interferon/ribavirin treatment in HIV/HCV co-infected patients.

Jain MK, Adams-Huet B, Terekhova D, Kushner LE, Bedimo R, Li X, Holodniy M 2014 Feb J. Viral Hepat.

The RADAR Study: Week 48 Safety and Efficacy of RAltegravir Combined with Boosted DARunavir Compared to Tenofovir/Emtricitabine Combined with Boosted Darunavir in Antiretroviral-Naive Patients. Impact on Bone Health.

Bedimo RJ, Drechsler H, Jain M, Cutrell J, Zhang S, Li X, Farukhi I, Castanon R, Tebas P, Maalouf NM 2014 PLoS ONE 8 9 e106221

Knowledge and attitudes about hepatitis C virus (HCV) infection and its treatment in HCV mono-infected and HCV/HIV co-infected adults.

Chen EY, North CS, Fatunde O, Bernstein I, Salari S, Day B, Jain MK 2013 Oct J. Viral Hepat. 10 20 708-14

Pegylated interferon fractal pharmacokinetics: individualized dosing for hepatitis C virus infection.

Jain MK, Pasipanodya JG, Alder L, Lee WM, Gumbo T 2013 Mar Antimicrob. Agents Chemother. 3 57 1115-20

Patient perspectives on hepatitis C and its treatment.

North CS, Devereaux R, Pollio DE, Hong BA, Jain MK 2013 Jun Eur J Gastroenterol Hepatol

Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis.

Price H, Dunn D, Pillay D, Bani-Sadr F, de Vries-Sluijs T, Jain MK, Kuzushita N, Mauss S, Núñez M, Nüesch R, Peters M, Reiberger T, Stephan C, Tan L, Gilson R 2013 PLoS ONE 7 8 e68152

Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection.

Yopp AC, Subramanian M, Jain MK, Mansour JC, Schwarz RE, Balch GC, Singal AG 2012 Nov Clin. Gastroenterol. Hepatol. 11 10 1284-90

Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis.

Jain MK, Seremba E, Bhore R, Dao D, Joshi R, Attar N, Yuan HJ, Lee WM 2012 Feb AIDS Patient Care STDS 2 26 73-80

A single nucleotide polymorphism in IL28B affects viral evolution of hepatitis C quasispecies after pegylated interferon and ribavirin therapy.

Yuan H, Adams-Huet B, Petersen T, Attar N, Lee WM, Jain MK 2012 Dec J. Med. Virol. 12 84 1913-9

Hepatitis B virus genotype G: Prevalence and impact in patients co-infected with human immunodeficiency virus.

Dao DY, Balko J, Attar N, Neak E, Yuan HJ, Lee WM, Jain MK 2011 Sep J. Med. Virol. 9 83 1551-8

Host-based ribavirin resistance influences hepatitis C virus replication and treatment response.

Ibarra KD, Jain MK, Pfeiffer JK 2011 Jul J. Virol. 14 85 7273-83

Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*.

Yuan HJ, Jain M, Snow KK, Gale M, Lee WM 2010 Mar J. Viral Hepat. 3 17 208-16

Pegylated interferon and ribavirin promote early evolution of nonstructural 5A protein in individuals with hepatitis C who demonstrate a response to treatment.

Jain MK, Yuan HJ, Adams-Huet B, Reeck A, Shelton J, Attar N, Zhang S, Neumann AU, Carney DS, Gale M, Lee WM 2009 Sep J. Infect. Dis. 6 200 866-76

Gamma/Delta T cell mRNA levels decrease at mucosal sites and increase at lymphoid sites following an oral SIV infection of macaques.

Kosub DA, Durudas A, Lehrman G, Milush JM, Cano CA, Jain MK, Sodora DL 2008 Nov Curr. HIV Res. 6 6 520-30

Gamma/Delta T-cell functional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections.

Kosub DA, Lehrman G, Milush JM, Zhou D, Chacko E, Leone A, Gordon S, Silvestri G, Else JG, Keiser P, Jain MK, Sodora DL, 2008 Feb J. Virol. 3 82 1155-65

Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.

Bräu N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, Trikha A, Sherman M, Sulkowski MS, Dieterich DT, Rigsby MO, Wright TL, Hernandez MD, Jain MK, Khatri GK, Sterling RK, Bonacini M, Martyn CA, Aytaman A, Llovet JM, Brown ST, Bini EJ 2007 Oct J. Hepatol. 4 47 527-37

Hepatitis C is associated with type 2 diabetes mellitus in HIV-infected persons without traditional risk factors.

Jain MK, Aragaki C, Fischbach L, Gibson S, Arora R, May L, Vardhineni K, Lee WM 2007 Nov HIV Med. 8 8 491-7

Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.

Jain MK, Comanor L, White C, Kipnis P, Elkin C, Leung K, Ocampo A, Attar N, Keiser P, Lee WM 2007 Mar J. Viral Hepat. 3 14 176-82

Do HIV care providers appropriately manage hepatitis B in coinfected patients treated with antiretroviral therapy?

Jain MK, Opio CK, Osuagwu CC, Pillai R, Keiser P, Lee WM 2007 Apr Clin. Infect. Dis. 7 44 996-1000

A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115.

Riddler SA, Jiang H, Tenorio A, Huang H, Kuritzkes DR, Acosta EP, Landay A, Bastow B, Haas DW, Tashima KT, Jain MK, Deeks SG, Bartlett JA, 2007 Antivir. Ther. (Lond.) 4 12 531-41

Gonoccocal Retropharyngeal Abscess Complicated by Cervical Osteomyelitis in a Patient with Acquired Immunodeficiency Syndrome

Reddy S, Jain M, Horan K, Skiest D, Gander R 2001 10 275-278